arrow
B

Bertram Wiedenmann

Charité—Universitätsmedizin Berlin
H指数:105
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Small intestinal neuroendocrine tumors lack early genomic drivers, acquire DNA repair defects and harbor hallmarks of low REST expression

小肠神经内分泌肿瘤缺乏早期基因组驱动因素,获得DNA修复缺陷,并具有低REST表达的特征。

2025-05-230
OA
SYSTEMIC DELIVERY OF LOW ENERGY RADIOFREQUENCY ELECTROMAGNETIC FIELDS FOR THE TREATMENT OF PATIENTS WITH PRIMARY BRAIN TUMORS
2024-11-110
PRE
Decoding spatiotemporal transcriptional dynamics and epithelial fibroblast crosstalk during gastroesophageal junction development through single cell analysis
2024-04-092
OAAI
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence
2022-07-040
OA
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence
2022-05-187
OA
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

神经内分泌肿瘤分子影像学研究的ENETS标准化 (概要) 报告

2021-10-209
OA
SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model

胰腺癌异种移植模型中177Lu-DOTA-Integrin αvβ6胱氨酸结肽的SPECT/CT成像,生物分布和辐射剂量

2021-05-3110
OAAI
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement

多发性内分泌肿瘤1型和胰腺: MEN1综合征内功能性和无功能性胰腺和十二指肠神经内分泌肿瘤的诊断和治疗-国际共识声明

2020-09-2474
OAAI
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors-Results from an Exploratory Study

神经内分泌肿瘤患者的miR-29血清水平分析-探索性研究的结果

2020-09-0610
OAAI
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

神经内分泌恶性肿瘤患者的可溶性尿激酶纤溶酶原激活物受体 (suPAR) 浓度升高

2020-05-319
OAAI